Aceto has announced the acquisition of Syntor Fine Chemicals, manufacturer of fine chemicals for pharmaceutical and other life sciences end markets.
Acquisition Part of Aceto’s Growth Plan
The acquisition of Syntor is an important step in Aceto’s strategic growth plan. Syntor’s synthesis and formulation capabilities will enhance Aceto’s existing services. With the addition of Syntor’s technical team, Aceto can provide greater product customization in addition to supplying the current offering of high-quality, specialty materials.
“
The two companies are well aligned in their culture and drive to maximize value to customers through sourcing and development of complex chemistries. We believe Syntor will thrive with the support of Aceto’s global infrastructure and we look forward to contributing to the next stage of growth for the combined company,” said Simon Knowles, managing partner of Syntor.
Benefits Customers and Supply Partners
The acquisition of Syntor represents significant progress in New Mountain’s strategic plan for Aceto, as the company continues its track record of growth both organically and through acquisition. The partnership creates significant cross-sell opportunities that benefit customers and supply partners to both businesses.
Syntor will operate under the name “Syntor by Aceto,” and it is intended that all employees will be retained in their current roles.
Source: Aceto